NMN (Nicotinamide Mononucleotide)
Category: NAD+ Precursor / Dietary Supplement Form: [Capsule / Powder / Sublingual tablet — select per SKU] Intended Use: Dietary supplement
Overview
NMN (nicotinamidum mononucleotidum) est molecula naturalis in familia vitaminis B3.Est praecursor directus NAD+ (nicotinamidum adeninum dinucleotidum), coenzymi necessarii.NAD+ est necessarium metabolismi energiae cellularis, reparationi DNA, et activitati sirtuinorum. NAD+ levels decline naturally with age, which has made NMN one of the most widely studied compounds in longevity and metabolic health research.
Specifications
- Purity: ≥99% (see Certificate of Analysis for batch-specific results)
- Serving size: [insert per SKU, e.g. 250mg / 500mg per capsule]
- Servings per container: [insert per SKU]
- Third-party tested: Independently verified for purity and heavy metal screening
- Storage: Store in a cool, dry place away from direct sunlight
Quality Assurance
Each batch is accompanied by a third-party Certificate of Analysis (COA) verifying purity and identity, available on request or via the product page prior to purchase.
Research Background
NMN has been studied in preclinical and early human trials for its role in raising NAD+ levels and supporting cellular energy metabolism. Human trial data is still limited relative to the compound’s popularity — most published studies to date are short-term and involve modest sample sizes, and NMN has not been shown to extend human lifespan or treat any disease.
Regulatory Note
As of late 2025, the FDA confirmed that NMN is not excluded from the definition of a dietary supplement under DSHEA, reversing its earlier 2022 exclusion. This product is manufactured in accordance with dietary supplement regulations.
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before use, especially if pregnant, nursing, or taking medication.


Reviews
There are no reviews yet.